That is why the European Respiratory Society is one of four founding societies, along with the European Association for the Study of Diabetes, the European Society of Cardiology and the European Cancer Organisation, of the Alliance for Biomedical Research in Europe, which aims to change the current fragmented and uncoordinated approach
for biomedical research funding, by giving a single, powerful voice to the biomedical research community across Europe.
Not exact matches
• Nexcelom Bioscience, a Lawrence, Mass. - based provider of cell counting and analysis products
for biomedical research and the biopharma industry, raised
funding of an undisclosed amount.
She currently serves as President and Executive Director and as a member of the board of directors of the Foundation
for the National Institutes of Health (FNIH), an independent 501 (c)(3) charitable organization established by Congress to support the mission of the National Institutes of Health (NIH) by raising private
funds for biomedical research and fostering partnerships and alliances around the world.
Recent Activity RCP Assesses Mississippi Program's Novel Public Health and Community Engagement Partnership In March 2017, RCP conducted an assessment of the Mississippi IDeA Network
for Biomedical Research Excellence (Mississippi INBRE) program, a five - year cycle - competitive $ 20 million NIH - funded program designed to enhance biomedical research capacity throughout th
Research Excellence (Mississippi INBRE) program, a five - year cycle - competitive $ 20 million NIH -
funded program designed to enhance
biomedical research capacity throughout th
research capacity throughout the state.
AAU and the Federation of American Societies
for Experimental Biology both call the president's 2006 request «disappointing,» with FASEB adding that the proposed
funding levels could «discourage our most talented young people from pursuing careers in
biomedical research.»
► In this week's issue of STM, Arthur Levine, senior vice chancellor
for the health sciences and dean of the University of Pittsburgh School of Medicine in Pennsylvania, and 18 other U.S. academic medical center leaders wrote that «[u] nstable
funding for biomedical research has created a hostile working environment that erodes the time available
for investigators to conduct their
research, discourages innovative high - risk science, threatens to drive established investigators out of U.S. academic
biomedical research, and creates uncertainty
for trainees and early - career investigators.
«Global health leaders call
for global
biomedical research and development
fund, mechanism.»
On 28 October, she told the Boston Chamber of Commerce that Congress needs «to double our investment in scientific and
biomedical research and create more year - to - year certainty
for that
funding.»
In advance of this month's World Health Assembly and the G7 summit in June, world leaders should consider the establishment of a global
biomedical research and development
fund and a mechanism to address the dearth in innovation
for today's most pressing global health challenges, according to Bernard Pécoul, from the Drugs
for Neglected Diseases Initiative, Geneva, Switzerland, and colleagues in an Essay published in PLOS Medicine.
► Tuesday also offered some rare good news
for the U.S.
biomedical research funding situation.
««This bill will put a plan in place
for the Appropriations Committee to reverse the 10 - year retrenchment in
biomedical research funding over the remaining years of the Budget Control Act,» Harkin said in July when he introduced the legislation, called the Accelerating Biomedical Research Act
research funding over the remaining years of the Budget Control Act,» Harkin said in July when he introduced the legislation, called the Accelerating
Biomedical Research Act
Research Act.»
When GrantsNet started in 1998, it focused on
biomedical -
research funding from private foundations and other not -
for - profit organizations.
The bill «ends the downward spiral in
funding for lifesaving
biomedical research.»
This award scheme allows researchers who can demonstrate an appropriate track record in chemisty, physics, or economics to apply
for funding to investigate and develop ideas, skills, and collaborations in the area of
biomedical research.
They see it as an attempt to undermine a program that
biomedical lobbyists have complained is supporting low - quality
research at a time when excellent proposals from top scientists are being rejected
for lack of
funds.
For this we need to acknowledge the wisdom of our elected officials in generously funding the National Institutes of Health (NIH) and the effectiveness of the Federation of American Societies for Experimental Biology and other scientific organizations in convincing politicians of the value of biomedical resear
For this we need to acknowledge the wisdom of our elected officials in generously
funding the National Institutes of Health (NIH) and the effectiveness of the Federation of American Societies
for Experimental Biology and other scientific organizations in convincing politicians of the value of biomedical resear
for Experimental Biology and other scientific organizations in convincing politicians of the value of
biomedical research.
Now he stands a chance to become one of the most powerful Dems in Congress, which can only mean good news
for fans of
biomedical research funding.
«We hope that we can still change things,
for the good of
biomedical research and
for the benefit of patients,» says Nathalie Kayadjanian, senior scientific officer
for the medical scientific committee of Science Europe, a group of science
funders and
research organizations.
In addition to $ 195 million to
fund a new cancer
research «Moonshot,» the administration proposes $ 33 billion
for the NIH to increase
biomedical research.
The
biomedical community «is going to miss [Obey] very much,» says David Moore, senior director
for government relations at the Association of American Medical Colleges in Washington, D.C. Moore says that Obey had a rare understanding of the need to
fund research and health professions over the long term.
Facebook couple's San Francisco, California,
biomedical research institute awards more than $ 50 million in
funding for high - risk
research
In a watershed moment
for chimpanzee
research, the U.S. Institute of Medicine (IOM) released a report on December 15 declaring that «most current use of chimpanzees
for biomedical research is unnecessary» and recommending the sharp curtailing of government -
funded research on humankind's closest genetic relative.
Between 1986 and 1995, federal
funding for biomedical research almost doubled, with half of those dollars allocated to academic
research, and much of that portion allotted to medical schools.
Part of that risk is in
funding: Budgets
for biomedical research are tight and may remain so
for several years.
For biomedical research involving chimpanzees, the IOM committee said that NIH should limit funding to studies for which there is no other suitable model available; that can not be performed ethically in humans; and without which important advancements will be significantly slowed or prevent
For biomedical research involving chimpanzees, the IOM committee said that NIH should limit
funding to studies
for which there is no other suitable model available; that can not be performed ethically in humans; and without which important advancements will be significantly slowed or prevent
for which there is no other suitable model available; that can not be performed ethically in humans; and without which important advancements will be significantly slowed or prevented.
Time will tell whether institutions and
funding agencies will sustain support
for translational
research and continue to plumb the storehouse of basic
biomedical advances to help sick people.
The NIH has not
funded new
research involving chimps since December 2011, when the Institute of Medicine, a nonprofit that advises the government on health policy, issued a report establishing strict criteria
for the use of chimps in
biomedical and behavioral
research.
One way, Tilghman said, would be
for NIH to shift
funding from R01
research grants, which currently support the majority of graduate students in
biomedical sciences, to NIH training grants, which are peer - reviewed by NIH
for their training - related virtues.
NIH is the most important source of
research funds for biomedical research, but don't forget that there are many other sources.
In a major policy shift that is reverberating across the
biomedical research community, the National Institutes of Health (NIH) in Bethesda, Maryland, says it plans to cap the number of grants an investigator can hold in order to free up
funding for early - career scientists and those struggling to keep their labs afloat.
Last week, a coalition of
biomedical research advocacy groups and a Washington, D.C. — based think tank released a report outlining a number of strategies
for sustaining the more than $ 30 billion budget of the National Institutes of Health (NIH), which provides about one - half of all U.S.
funding for basic
research.
NIH Director Francis Collins (fourth from left) urged the audience at a
Research!America forum to push
for more
biomedical research funding.
As chief of the parent agency of the National Institutes of Health (NIH), Sebelius defended the importance of sustained
funding for biomedical research, yet oversaw administration requests to keep NIH's
funding essentially flat.
A statement just in from Carrie Wolinetz, president, United
for Medical
Research, a coalition that works to boost biomedical research
Research, a coalition that works to boost
biomedical research research funding.
«The so - called 21st Century Cures Act contains huge news
for supporters of
biomedical research: It recommends substantial budget increases
for the National Institutes of Health (NIH), including $ 10 billion in extra
funding over 5 years.
Innovations in
Biomedical Computational Science and Technology Initiative (SBIR) Innovations in
Biomedical Computational Science and Technology Initiative (STTR) These programs apply to all NIH institutes and
fund basic
research in
biomedical computing, as well as development of informatics tools
for the health sciences.
United
for Medical
Research (UMR), a politically potent coalition of leading research universities, industry groups, and patient advocates based in Washington, D.C., isn't happy with Trump's proposed 20 % cut to the $ 32 billion NIH, the nation's major funder of basic biomedical
Research (UMR), a politically potent coalition of leading
research universities, industry groups, and patient advocates based in Washington, D.C., isn't happy with Trump's proposed 20 % cut to the $ 32 billion NIH, the nation's major funder of basic biomedical
research universities, industry groups, and patient advocates based in Washington, D.C., isn't happy with Trump's proposed 20 % cut to the $ 32 billion NIH, the nation's major
funder of basic
biomedical science.
By Jennifer Nguyen The
biomedical research enterprise has been dealing with a tight
funding environment
for over a decade, and universities have struggled to adjust their finances accordingly.
As America's patient lobby groups win increasing support
for research into their own «pet diseases», scientists working at the more basic end of
biomedical research are struggling to win a share of the
funds.
He refocused the BRIDGES program while functioning temporarily as its acting director, created the Postbaccalaureate
Research Education Program, encouraged professional societies to apply for funding to increase the participation of underrepresented students in biomedical and behavioral research, and established the Annual Biomedical Research Conference for Minority S
Research Education Program, encouraged professional societies to apply
for funding to increase the participation of underrepresented students in
biomedical and behavioral
research, and established the Annual Biomedical Research Conference for Minority S
research, and established the Annual
Biomedical Research Conference for Minority S
Research Conference
for Minority Students.
Cross
funded by AFM - Téléthon and INSERM in 2005, I - Stem also joined the AFM - Téléthon Biotherapies Institute
for Rare Diseases last 2012 which is an unrivalled strike force and a world reference hub in translational
biomedical research and innovative medicines.
The aim of Maine INBRE, which is
funded through the National Institutes of Health, is to create a
biomedical training and
research ecosystem
for Maine to catalyze innovation and drive the creation of 21st - century jobs
for Maine students.
LGG has been a member of numerous Study Sections at the NIH and the ERC
for the allocation of
funds to
biomedical research.
At the end of his talk, Collins urged researchers to continue to ask congress to
fund more
for fundamental
research, arguing that increased, sustainable
funding will help maintain support
for model organisms, and the
biomedical advances that depend on them
Many U.S. scientists had hoped to ride out the steady decline in federal
funding for biomedical research, but it's continuing on a downward trend with no end in sight.
The current
funding environment has raised serious concerns about the long - term viability of the
biomedical research enterprise, as securing NIH grants has become increasingly difficult
for scientists early in their careers.
It declared that all patients should have affordable access to appropriate drugs, but also underscored that sustained
funding for cancer
research and partnerships between private
biomedical firms and non-profit
research institutions are essential.
The Society supports robust, predictable, sustainable federal
funding of
biomedical research to fuel these advances while ensuring that there is support
for training the next generation of geneticists and a career pathway
for our future leaders in the field.
As a citizen of the United States and a taxpayer, and as a practicing
biomedical applied statistician, I am especially concerned about the possibility that the
funding garnered
for such potentially flawed studies is detracting from other groups» ability to obtain
funding to perform valid
research in the valuable arena of personalized medicine.
The ASHG Advocacy Award, new in 2015, honors individuals or groups who have exhibited excellence and achievement in applications of human genetics
for the common good, in areas such as facilitating public awareness of genetics issues, promoting
funding for biomedical research, and integrating genetics into health systems.